Interv Akut Kardiol. 2018;17(1):34-35 | DOI: 10.36290/kar.2018.032

Warfarin-related nephropathy

Bronislav Janek
Klinika kardiologie IKEM, Praha

Warfarin-related nephropathy is a relatively new nosological entity. It is characterized by an acute kidney injury due to over-warfarinizationwithin a week of its detection. It more frequently occurs in chronic kidney disease, and other risks for developingthe condition include concurrent treatment with acetylsalicylic acid, older age, diabetes mellitus, proteinuria, hypertension, andheart failure. Treatment is mainly supportive and reversibility of renal injury is usually partial only. Therefore, prevention and earlydetection of warfarin-related nephropathy, while using the proposed procedures, are essential.

Keywords: warfarin-related nephropathy, supratherapeutic INR level, treatment, prevention

Published: April 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janek B. Warfarin-related nephropathy. Interv Akut Kardiol. 2018;17(1):34-35. doi: 10.36290/kar.2018.032.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011; 365(21): 2002-2012. Go to original source... Go to PubMed...
    2. Souhrn údajů o přípravku Warfarin Orion 3 a 5 mg tablety. Revize z 6. 10. 2016.
    3. Limdi NA, Nolin TD, Booth SL, et al. Influence od kidney function on risk of supratherapeutic International Normalized Ratio-related hemorrhage in warfarin users: a prospective cohort study. Am J Kidney Dis 2015; 65(5): 701-709. Go to original source... Go to PubMed...
    4. Brodsky SV, Satoskar A, Chen J, et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis. 2009; 54: 1121-1126. Go to original source... Go to PubMed...
    5. Ware K, Brodsky P, Satoskar AA, et al. Warfarin related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol. 2011; 22: 1856-1862. Go to original source... Go to PubMed...
    6. Ware K, Qamri Z, Ozcan A, et al. N-acetylcystein ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Physiol Renal Physiol 2013; 304(12): F1421-1427. Go to original source... Go to PubMed...
    7. Kapoor KG, Bekaii-Saab T. Warfarin induced allergic interstitial nephritis and leucocytoclastic vasculitis. Inter Med J 2008; 38(4): 281-283. Go to original source... Go to PubMed...
    8. Brodsky SV, Nadasdy T, Rovin BH, et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 2011; 80: 181-189. Go to original source... Go to PubMed...
    9. Wheeler DS, Giugliano RP, Rangaswami J. Anticoagulation-related nephropathy. J Thromb Haemost. 2016; 14(3): 461-467. Go to original source... Go to PubMed...
    10. Di Maso V, Carraro M, Bevilacqua E, et al. Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile. Clin Kidney J. 2014; 7(6): 605-608. Go to original source... Go to PubMed...
    11. Böhm M, Ezekovitz MD, Conolly SJ, et al. Changes in renal function in patients with atrial fibrillation: an analysis from RE-LY trial. J Am Coll Cardiol, 2015; 65: 2481-2493. Go to original source... Go to PubMed...
    12. Ryan M, Ware K, Qamri Z, et al. Warfarin-related nephropathy is the tip of the iceberg: direct trombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant 2014; 29: 2228-2234. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.